ACIP recommends that people 60 yo receive a single dose of RSV vaccine using shared clinical decision making FDA has approved 2 vaccines for preventing RSV LRTI in this age group

By rray, 31 October, 2023
Exclude Patient Type Detail Header
No
Footnote
<sup>1</sup> <b>CDC 2023.</b> Melgar M, et al. Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023. <i>MMWR Morb Mortal Wkly Rep.</i> 2023 Jul 21;72(29):793-801. <a href=https://www.cdc.gov/mmwr/volumes/72/wr/mm7229a4.htm><u>Free, full-text article</u></a>
Detail Type
Text
Patient Type Detail Header (Long)
ACIP recommends that people ≥60 yo receive a single dose of RSV vaccine, using shared clinical decision-making. FDA has approved 2 vaccines for preventing RSV LRTI in this age group: